Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
YS Biopharma Co., Ltd. - Ordinary Shares
(NQ:
YS
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.010 (1)
Ask (Size)
1.020 (1)
Prev. Close
1.020
Today's Range
N/A - N/A
52wk Range
0.3503 - 1.030
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
YS Stock Earnings: YS Biopharma Co Misses EPS, Beats Revenue for Q3 2024
April 19, 2024
YS stock results show that YS Biopharma Co missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
Via
InvestorPlace
Chinese Biotech YS Biopharma's Next-Gen Rabies Vaccine Non-Inferior To Approved Competitor
April 09, 2024
YS Biopharma unveils interim results from Phase 3 trial of PIKA Rabies Vaccine, meeting primary endpoints. With accelerated immunity in 7 days, it could revolutionize rabies prevention.
Via
Benzinga
Performance
More News
Read More
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 05, 2024
Via
Benzinga
Shareholders of YS Biopharma Announce an Extraordinary General Meeting
February 12, 2024
Via
GlobePRwire
YS Stock Earnings: YS Biopharma Co Misses EPS, Misses Revenue for Q2 2024
January 22, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 26, 2023
Via
Benzinga
3 Penny Stocks That Are Too Compelling to Ignore
December 19, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
October 05, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 15, 2023
Via
Benzinga
Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 29, 2023
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 29, 2023
Via
Benzinga
Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
August 29, 2023
Via
Benzinga
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 28, 2023
Via
Benzinga
Why LQR House Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
August 28, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
August 28, 2023
Via
InvestorPlace
Nasdaq Gains Over 100 Points; YS Biopharma Shares Spike Higher
August 25, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Nordstrom Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
August 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 25, 2023
Via
Benzinga
Why YS Biopharma Stock Is Rocketing Higher
August 25, 2023
Via
Benzinga
Nasdaq Edges Lower; Domo Shares Plummet
August 25, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Jumps Over 200 Points; Hibbett Posts Upbeat Earnings
August 25, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.